Medicare go-broke date pushed up three years in latest trustees report
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter.
A key trust fund underpinning Medicare's hospital benefit will go broke three years earlier than previously expected absent congressional action, threatening benefits for seniors, according to the Medicare trustees' annual report released Wednesday.
The Medicare Hospital Insurance trust fund will be depleted in 2033, instead of 2036, as Medicare spending continues to outpace the program's income, the trustees — a group comprised of the HHS, Treasury and Labor secretaries, along with the Social Security commissioner — warned.
The bleaker outlook is due to higher-than-expected spending for hospital care, hospice services and physician-administered drugs. The trustees called on Congress to act quickly to stabilize Medicare, though near-term action is unlikely as the Republican majority focuses on advancing their reconciliation megabill.
Medicare has been teetering on the edge of insolvency for a while. But the latest report from Medicare's trustees is more dire than last year's, which projected Medicare would become insolvent in more than a decade.
Now, Medicare's hospital trust fund will start running out of money in eight years — when today's 57-year-olds first become eligible for the program.
The looming go-broke date is a result of the fund's substantial shortfall as Medicare costs continue to grow rapidly, trustees said in the report. Medicare costs are expected to increase from 3.8% of the gross domestic product in 2024 to 6.2% in 2050 before reaching 6.7% in 2099, the report projects.
Costs to another fund that pays Parts B and D, called the Supplemental Medical Insurance trust fund, are also climbing, increasing pressure on beneficiary budgets and the federal budget. (Though, the Supplemental Medical Insurance trust fund is largely funded by premiums and general revenue that resets each year and doesn't face the same solvency concerns.)
This year's estimates, which are based on current payment rates, could be conservative, trustees said. Under an alternate scenario, in which provider payments grow at a rate more consistent with underlying medical costs — a change aggressively lobbied for by physician associations — Medicare spending will rise to 8.8% of the GDP in 2099 rather than 6.7%, according to the report.
The precarious footing of the federal insurance program, which covers almost 69 million people in the U.S., is due to the country's underlying demographic shifts, according to experts.
More and more Americans are aging into Medicare, while at the same time the number of workers paying into its trust fund is dropping. More seniors are also selecting privatized Medicare Advantage plans, which are more expensive than traditional Medicare coverage.
If and when the U.S. hits Medicare's go-broke date, the hospital trust fund, which pays hospitals and providers of post-acute services and also covers some of the cost of private Medicare Advantage plans, will have inadequate income to fund those benefits. Medicare payments would immediately be cut by 11%, according to the report. Those cuts would grow over time, likely disrupting services for seniors and reimbursement for providers.
It's worth nothing that there's a significant degree of uncertainty in trustees' projections, which vary based on macroeconomic forces in a given year.
For example, in 2020, in the early throes of COVID-19, the board predicted the hospital trust fund would run out by 2026. That deadline was pushed back to 2028 and then 2031 in subsequent years' reports, amid a broader economic rebound and more care shifting to cheaper outpatient settings.
Still, the fund hasn't met the trustees' test for short-range financial adequacy since 2003, and has triggered funding warnings since 2018.
To date, Congress has not allowed Medicare to go under. But legislators' lack of action despite years of warnings is a source of heartburn for budget hawks, Medicare advocates and physician lobbies.
Experts say lawmakers need to act soon given many reforms to stabilize Medicare could take a few years to go into effect.
'The projections in this report show that change is needed to address Medicare's financial challenges,' the Medicare trustees wrote in their report. 'The sooner solutions are enacted, the more flexible and gradual they can be.'
According to the Committee for a Responsible Federal Budget, restoring Medicare solvency would require Congress to boost the payroll tax rate by 14% or reduce Medicare spending by 9% — both politically unappetizing proposals.
Other reforms that could curb Medicare spending, like implementing site-neutral payments or reducing overpayments in MA, have more bipartisan support but aren't a policy priority on the Hill. Republicans are currently focused on hammering out legislation to extend tax cuts from President Donald Trump's first term, cut green energy programs, fund border control and curb Medicaid spending.
'We are running out of time to phase in changes gradually and avoid harsh cuts, sharp tax increases, or unacceptable borrowing. Demagoguing this issue may be politically expedient, but it will ultimately prove ruinous for the tens of millions of Americans that rely on the programs,' Maya MacGuineas, the president of the CRFB, said in a statement Wednesday.
Recommended Reading
Medicare go-broke date extended to 2036, but warning bells continue ringing
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Think Celsius Holdings Stock Is Expensive? This Chart Might Change Your Mind
Amid heavy volatility, one particular valuation metric offers signs of hope for investors looking to add shares now. Profit growth is likely on the way to recovery. 10 stocks we like better than Celsius › Has Celsius Holdings (NASDAQ: CELH) become an expensive stock? Investors who don't examine the stock closely might believe so. Its price-to-earnings (P/E) ratio now exceeds 143, a dramatic surge from last fall, when it fell to just above 30. Nonetheless, a less commonly cited financial metric may cause investors to rethink its valuation. The question for investors is whether evaluating that metric might change perceptions of Celsius' valuation and the stock's value proposition in general. The financial metric that might cause investors to view Celsius differently is the forward P/E ratio. Instead of measuring trailing earnings like the standard earnings multiple, the forward P/E measures the price divided by the expected earnings over the following 12 months. In this case, the forward P/E ratio stands at about 55. This is far below early 2024 levels, when the forward earnings multiple briefly surpassed 140 amid a higher stock price. Still, it is higher than mid-February, when the forward P/E had fallen as low as 26. Additionally, its earnings growth had again turned positive. In the first quarter of 2025, net income fell to $44 million, versus $78 million in the year-ago quarter. Consequently, the lower profits pushed the trailing P/E ratio higher. Now, analysts forecast 18% higher earnings in 2025 and 40% profit growth in the following year. Such earnings increases likely mean Celsius will generate enough growth to justify its 55 forward P/E ratio. Furthermore, despite gaining more than 70% year to date, it may surprise investors to see that Celsius stock sells at almost a 55% discount to the all-time high reached in early 2024. This leaves plenty of room for the beverage stock to go higher as it surges back toward record highs. Before you buy stock in Celsius, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Celsius wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,731!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $945,846!* Now, it's worth noting Stock Advisor's total average return is 818% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Will Healy has positions in Celsius. The Motley Fool has positions in and recommends Celsius. The Motley Fool has a disclosure policy. Think Celsius Holdings Stock Is Expensive? This Chart Might Change Your Mind was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Analyst Says He's Buying Cisco (CSCO) Amid Attractive Valuation – ‘Definitely Benefitting from AI'
Jim Lebenthal from CNBC Investment Committee said in a recent program on CNBC that he's buying Cisco Systems Inc (NASDAQ:CSCO) shares. "Cisco Systems Inc (NASDAQ:CSCO), if you look at the earnings revisions, is definitely going higher and it's with good reason. If you've listened to their last several earnings calls, they are definitely benefiting from AI, definitely benefiting from the data center buildout, and it's just not reflected in the multiple," he said. Engineers using the latest Cisco TelePresence technology to collaborate with colleagues around the world. GreensKeeper Asset Management stated the following regarding Cisco Systems, Inc. (NASDAQ:CSCO) in its Q3 2024 investor letter: 'In the third quarter, we decided to exit our investment in Cisco Systems, Inc. (NASDAQ:CSCO), as we believed the stock had become fully valued and reallocated the capital to one of our international positions. We also initiated a new position in a Canadian company shortly after the quarter ended. As we may still accumulate shares, we will defer discussing this new holding for the time being. Our top ten positions are detailed in the table below. Further portfolio disclosures, including performance statistics, are available on the pages immediately following this letter.' While we acknowledge the potential of CSCO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Jessica Inskip Explains AI Growth Catalysts for IBM Stock
Jessica Inskip from recently said while talking to Schwab Network that she likes International Business Machines (NYSE:IBM) because of the company's growth catalysts related to enterprise and AI. 'I've liked IBM for quite some time because it's an enterprise solution that offers consulting but also a lot of technology solutions for enterprises. And that's really important as we think about AI. We want to see our investors—really, the market wants to see that—translate into earnings, and IBM is the leader in that and the beginner of that.' Inskip also talked about a recent bullish call on IBM Common Stock (NYSE:IBM) from Wall Street: 'On top of that, the headline that caught my attention today was that with Deutsche Bank, where they were praising IBM for helping to modernize and strengthen their infrastructure. That IBM had a very large role in their large-scale digital transformation. And on top of that, AI plus cloud tailwinds. So if we think about the needs for AI, if you're a company and you're not on the cloud, that's step one in order for you to access AI and start getting those types of solutions. IBM is a solution for you. So with growing exposure to cloud migration and AI, IBM's positioned for that. They are absolutely going to capture that, and it's an essential enterprise infrastructure for AI but also blockchain and cloud.' Photo by Ruben Sukatendel on Unsplash As of the end of Q4, IBM's AI products and services surpassed $5 billion in total bookings, with $2 billion added just since last quarter. Last year, IBM updated its Granite family of AI models for enterprise use, making them about 90% more cost-efficient than large models. RedHat is also key in IBM's open-source GenAI strategy. Management highlighted that RHEL AI and OpenShift AI platforms are gaining traction, along with IBM's watsonx AI solutions. The company expects its software business to grow by at least 10% in 2025, up from 8.3% growth in 2024. While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.